Nobuhiro Nakazawa

646 total citations
65 papers, 394 citations indexed

About

Nobuhiro Nakazawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nobuhiro Nakazawa has authored 65 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 26 papers in Surgery. Recurrent topics in Nobuhiro Nakazawa's work include Gastric Cancer Management and Outcomes (28 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Esophageal Cancer Research and Treatment (13 papers). Nobuhiro Nakazawa is often cited by papers focused on Gastric Cancer Management and Outcomes (28 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Esophageal Cancer Research and Treatment (13 papers). Nobuhiro Nakazawa collaborates with scholars based in Japan, France and Switzerland. Nobuhiro Nakazawa's co-authors include Ken Shirabe, Takehiko Yokobori, Makoto Sohda, Akihiko Sano, Yasunari Ubukata, Hiroshi Saeki, Makoto Sakai, Hiroyuki Kuwano, Kyoichi Ogata and Hiroomi Ogawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Nobuhiro Nakazawa

58 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiro Nakazawa Japan 12 141 111 102 100 40 65 394
Hiromichi Yamai Japan 10 120 0.9× 125 1.1× 106 1.0× 188 1.9× 28 0.7× 34 410
Anmei Zhang China 13 92 0.7× 113 1.0× 157 1.5× 89 0.9× 47 1.2× 26 495
Chun‐Hung Hua Taiwan 14 93 0.7× 100 0.9× 189 1.9× 124 1.2× 31 0.8× 32 545
Wonwoo Kim South Korea 13 109 0.8× 55 0.5× 128 1.3× 137 1.4× 44 1.1× 31 398
Jiazhen Li China 16 84 0.6× 92 0.8× 141 1.4× 80 0.8× 41 1.0× 50 510
Yongchen Ma China 11 126 0.9× 89 0.8× 185 1.8× 70 0.7× 44 1.1× 26 410
Qiang Yin China 13 78 0.6× 84 0.8× 133 1.3× 113 1.1× 38 0.9× 51 436
Mengjie Tang China 12 57 0.4× 79 0.7× 130 1.3× 106 1.1× 38 0.9× 44 389
Xiaojun Liu China 10 99 0.7× 51 0.5× 129 1.3× 65 0.7× 68 1.7× 30 365

Countries citing papers authored by Nobuhiro Nakazawa

Since Specialization
Citations

This map shows the geographic impact of Nobuhiro Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Nakazawa more than expected).

Fields of papers citing papers by Nobuhiro Nakazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Nakazawa. The network helps show where Nobuhiro Nakazawa may publish in the future.

Co-authorship network of co-authors of Nobuhiro Nakazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Nakazawa. A scholar is included among the top collaborators of Nobuhiro Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Nakazawa. Nobuhiro Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakazawa, Nobuhiro, Makoto Sohda, Mizuki Endo, et al.. (2024). The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients. Cancer Chemotherapy and Pharmacology. 94(4). 517–522.
2.
Nakazawa, Nobuhiro, Makoto Sohda, Munenori Ide, et al.. (2024). Poorly cohesive gastric cancer with increased epithelial‑mesenchymal transition is associated with a poor prognosis. Oncology Letters. 28(3). 420–420.
3.
Sakai, Makoto, Makoto Sohda, Takayoshi Watanabe, et al.. (2024). Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer: a systematic review and meta-analysis. Esophagus. 21(2). 95–101. 2 indexed citations
4.
Shiraishi, Takuya, Makoto Sohda, Nobuhiro Nakazawa, et al.. (2024). Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer. Oncology Letters. 27(3). 104–104. 3 indexed citations
5.
Sohda, Makoto, Takehiko Yokobori, Nobuhiro Nakazawa, et al.. (2024). Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer. Annals of Surgical Oncology. 32(3). 1913–1924. 3 indexed citations
6.
Yokobori, Takehiko, Makoto Sohda, Nobuhiro Nakazawa, et al.. (2023). Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy. International Journal of Molecular Sciences. 24(3). 2604–2604. 7 indexed citations
7.
Nakazawa, Nobuhiro, Takehiko Yokobori, Makoto Sohda, et al.. (2023). Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity. International Journal of Molecular Sciences. 24(14). 11790–11790. 4 indexed citations
8.
Nakazawa, Nobuhiro, Makoto Sohda, Ayaka Katayama, et al.. (2023). Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling. Oncology. 101(8). 520–526. 1 indexed citations
9.
Nakazawa, Nobuhiro, Makoto Sohda, Takayoshi Watanabe, et al.. (2023). Albumin–derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study. In Vivo. 37(2). 818–824. 4 indexed citations
10.
Sano, Akihiko, Makoto Sohda, Takayoshi Watanabe, et al.. (2023). Importance of Progression-free Survival in Second-line Chemotherapy in Patients With Advanced or Recurrent Gastric Cancer. Anticancer Research. 43(11). 5205–5213. 1 indexed citations
11.
Nakazawa, Nobuhiro, Makoto Sohda, Takehiko Yokobori, et al.. (2022). Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer. Annals of Gastroenterological Surgery. 6(4). 505–514. 5 indexed citations
12.
Nakazawa, Nobuhiro, Makoto Sohda, Takayoshi Watanabe, et al.. (2022). Preoperative Risk Factors and Prognostic Impact of Postoperative Complications Associated with Total Gastrectomy. Digestion. 103(6). 397–403. 3 indexed citations
13.
Sakai, Makoto, Makoto Sohda, Takayoshi Watanabe, et al.. (2021). Fibrin/fibrinogen Degradation Products Are Associated With Tumor Stage and Prognosis in Patients Undergoing Resection of Esophageal Cancer. Anticancer Research. 41(9). 4523–4527. 4 indexed citations
14.
Nakazawa, Nobuhiro, Makoto Sohda, Munenori Ide, et al.. (2021). High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients. Oncology. 99(11). 732–739. 8 indexed citations
15.
Sakai, Makoto, Makoto Sohda, Hideyuki Saito, et al.. (2020). Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer. The American Journal of Surgery. 221(1). 149–154. 8 indexed citations
16.
Nakazawa, Nobuhiro, Takehiko Yokobori, Kyoichi Kaira, et al.. (2019). High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors. Annals of Surgical Oncology. 27(3). 933–942. 30 indexed citations
17.
Nakazawa, Nobuhiro, Takehiko Yokobori, Andrei Turtoï, & Ken Shirabe. (2019). ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer. Annals of Surgical Oncology. 27(3). 943–944. 2 indexed citations
18.
Rahman, Md. Mizanur, et al.. (2018). Visualize the quality of frozen fish using fluorescence imaging aided with excitation-emission matrix. Optics Express. 26(18). 22954–22954. 17 indexed citations
19.
Nakazawa, Nobuhiro, et al.. (1995). IGTC-63 Development of Turbine Components for the 100kW Ceramic Gas Turbine(Session C-3 AUTOMOTIVE CERAMIC GAS TURBINES). 1995(3). 1 indexed citations
20.
Satoh, Hiroki, et al.. (1984). IGTC-77 DEVELOPMENT OF A VARIABLE GEOMETRY TURBOCHARGER FOR TRUCKS AND BUSES. 1983(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromichi Yamai Breakdown of academic impact, for papers by Anmei Zhang Breakdown of academic impact, for papers by Chun‐Hung Hua Breakdown of academic impact, for papers by Wonwoo Kim Breakdown of academic impact, for papers by Jiazhen Li Breakdown of academic impact, for papers by Yongchen Ma Breakdown of academic impact, for papers by Qiang Yin Breakdown of academic impact, for papers by Mengjie Tang Breakdown of academic impact, for papers by Xiaojun Liu
Rankless by CCL
2026